BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3292403)

  • 1. [Neuron-specific enolase and beta 2-microglobulin in the serum of patients with melanoma].
    Uerlich M; Biltz H; Kreysel HW
    Immun Infekt; 1988 Apr; 16(2):65-7. PubMed ID: 3292403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuron-specific enolase (NSE)--a suitable tumor marker in malignant melanoma?].
    Hornef S; Lux J; Rassner G
    Hautarzt; 1992 Feb; 43(2):77-80. PubMed ID: 1347764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relation between the level of TPS, NSE, CEA and beta2-mG in the serum and the biological behavior of small cell lung cancer].
    Chen MS; Xu Y; Ma J; Wu CG; Hao XK; Lu BB; Liu T
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Aug; 23(8):751-3. PubMed ID: 17618570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma.
    Wibe E; Hannisdal E; Paus E; Aamdal S
    Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
    Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuron-specific enolase--a serum marker for malignant melanoma.
    Lorenz J; Dippold W
    J Natl Cancer Inst; 1989 Nov; 81(22):1754-5. PubMed ID: 2810389
    [No Abstract]   [Full Text] [Related]  

  • 7. S-100 and NSE as serum markers in melanoma.
    Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL
    Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age dependence and prognostic impact of neuron specific enolase (NSE) in children with neuroblastoma.
    Berthold F; Engelhardt-Fahrner U; Schneider A; Schumacher R; Zieschang J
    In Vivo; 1991; 5(3):245-7. PubMed ID: 1893081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysing the serum levels of tumour markers and primary tumour data in stage III melanoma patients in correlation to the extent of lymph node metastases--a prospective study in 231 patients.
    Neuss H; Koplin G; Raue W; Reetz C; Mall JW
    Acta Chir Belg; 2011; 111(4):214-8. PubMed ID: 21954736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuron specific enolase (NSE) in serum of patients with malignant melanoma.
    Wibe E; Paus E; Aamdal S
    Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of serum neuron-specific enolase in patients with adult T-cell leukemia.
    Fujiwara H; Arima N; Ohtsubo H; Matsumoto T; Kukita T; Kawada H; Imaizumi R; Ozaki A; Matsushita K; Tei C
    Am J Hematol; 2002 Oct; 71(2):80-4. PubMed ID: 12353304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determining the level of the tumor marker--neuron-specific enolase in patients with neoplastic and non-neoplastic diseases].
    Romanova LF; Khaĭlenko VA; Kuznetsova LF; Davydov MI; Komov DV; Kulish VL; Platinskiĭ LV; Poddubskaia EV
    Klin Med (Mosk); 1991 Sep; 69(9):38-9. PubMed ID: 1803146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum neuron-specific enolase (NSE) in patients with primary lung cancer].
    Oribe H; Kato R; Noguchi S; Kai T
    Rinsho Byori; 1988 Apr; 36(4):464-8. PubMed ID: 2841516
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuron-specific enolase as a tumor marker in small cell bronchial carcinoma].
    Gasser RW; Herold M; Müller-Holzner E; Müller LC; Salzer GM; Huber H
    Dtsch Med Wochenschr; 1988 Nov; 113(44):1708-13. PubMed ID: 2846253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific enolase in small-cell carcinoma of the lung: the value of combined immunocytochemistry and serum determination.
    Esscher T; Bergh J; Steinholtz L; Nöu E; Nilsson K; Påhlman S
    Anticancer Res; 1989; 9(6):1717-20. PubMed ID: 2560624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuron specific enolase (NSE)].
    Odagiri E
    Nihon Rinsho; 1999 Dec; 57 Suppl():540-2. PubMed ID: 10778185
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuron-specific enolase as a tumor marker in metastatic melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of neuron specific enolase (NSE) in the cerebrospinal fluid of malignant brain tumor with intrathecal metastasis].
    Miyagami M; Tazoe M; Tsubokawa T
    No To Shinkei; 1989 Oct; 41(10):1021-7. PubMed ID: 2605041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of serum neuron-specific enolase in non-small cell lung cancer].
    Kimura H; Yamaguchi T; Nishino K; Nakagawa M; Yokota S; Nishikawa H; Ito M; Ogura T
    Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):128-32. PubMed ID: 9617138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuron-specific enolase as serum marker for malignant melanoma.
    Couvreur R; Joos G; Geerts ML; Lambert J; Naeyaert JM
    Lancet; 1993 Oct; 342(8877):985. PubMed ID: 8105228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.